329 related articles for article (PubMed ID: 15917659)
21. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.
Olie RA; Simões-Wüst AP; Baumann B; Leech SH; Fabbro D; Stahel RA; Zangemeister-Wittke U
Cancer Res; 2000 Jun; 60(11):2805-9. PubMed ID: 10850418
[TBL] [Abstract][Full Text] [Related]
22. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
Bang CI; Paik SY; Sun DI; Joo YH; Kim MS
Ann Otol Rhinol Laryngol; 2008 Oct; 117(10):781-5. PubMed ID: 18998509
[TBL] [Abstract][Full Text] [Related]
23. SPC3042: a proapoptotic survivin inhibitor.
Hansen JB; Fisker N; Westergaard M; Kjaerulff LS; Hansen HF; Thrue CA; Rosenbohm C; Wissenbach M; Orum H; Koch T
Mol Cancer Ther; 2008 Sep; 7(9):2736-45. PubMed ID: 18790754
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
Sartorius UA; Krammer PH
Int J Cancer; 2002 Feb; 97(5):584-92. PubMed ID: 11807782
[TBL] [Abstract][Full Text] [Related]
25. [Effect of survivin antisense oligodeoxynucleotide on carcinoma of larynx in vivo and in vitro].
Xiang C; Liu WS; Jia SS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jan; 41(1):60-4. PubMed ID: 16646247
[TBL] [Abstract][Full Text] [Related]
26. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
[TBL] [Abstract][Full Text] [Related]
27. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
28. Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models.
Rödel F; Frey B; Leitmann W; Capalbo G; Weiss C; Rödel C
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):247-55. PubMed ID: 18406888
[TBL] [Abstract][Full Text] [Related]
29. [Antisense oligonucleotide against survivin induces apoptosis and enhances adriamycin sensitivity of SMMC-7721/ADM cells].
Gao P; Fang CH; Zhang GQ; Yan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1644-7. PubMed ID: 17121723
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.
Skoda C; Erovic BM; Wachek V; Vormittag L; Wrba F; Martinek H; Heiduschka G; Kloimstein P; Selzer E; Thurnher D
Oncol Rep; 2008 Jun; 19(6):1499-503. PubMed ID: 18497956
[TBL] [Abstract][Full Text] [Related]
32. TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2.
Park SB; Lee JH; Jeong WW; Kim YH; Cha HJ; Joe Y; Chung HT; Cho WJ; Do JW; Lee BJ; Park JW; Ko BK
J Chemother; 2015 Jun; 27(3):174-80. PubMed ID: 25604244
[TBL] [Abstract][Full Text] [Related]
33. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
Song L; Coppola D; Livingston S; Cress D; Haura EB
Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells.
Kumar Biswas S; Huang J; Persaud S; Basu A
Mol Cancer Ther; 2004 Mar; 3(3):327-34. PubMed ID: 15026553
[TBL] [Abstract][Full Text] [Related]
36. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
Mercatante DR; Mohler JL; Kole R
J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
[TBL] [Abstract][Full Text] [Related]
37. S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy.
Khanna N; Sen S; Sharma H; Singh N
Biochem Biophys Res Commun; 2003 Apr; 304(1):26-35. PubMed ID: 12705879
[TBL] [Abstract][Full Text] [Related]
38. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis of drug-resistant human ovarian carcinoma cell line COC1/DDP induced by survivin antisense oligonucleotides.
Zheng F; Ruan F; Xie XK; Liu SY
Chin Med J (Engl); 2006 Sep; 119(18):1572-5. PubMed ID: 16996013
[No Abstract] [Full Text] [Related]
40. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).
Notarbartolo M; Cervello M; Dusonchet L; Cusimano A; D'Alessandro N
Cancer Lett; 2002 Jun; 180(1):91-101. PubMed ID: 11911975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]